No Data
No Data
HIRAYAMA Holdings: Interim report
HIRAYAMA Holdings: Notice regarding dividends from surplus funds
In June of the 24th year, Hirayama achieved double-digit growth in both revenue and profit, with revenue and profit growth in all segments.
On the 14th, Hiran Haldings, ticker number 7781, released its consolidated financial statements for the fiscal year ending in June 2024. Revenue increased by 11.4% from the previous year to 35.292 billion yen, operating profit increased by 25.3% to 1.119 billion yen, ordinary profit increased by 23.0% to 1.166 billion yen, and net income attributable to parent company shareholders increased by 37.9% to 0.757 billion yen. Revenue from the insourcing and dispatch business was 28.273 billion yen (an increase of 11.8% from the previous year), and segment profit was 1.619 billion yen (an increase of 12.3% from the previous year).
HIRAYAMA Holdings To Go Ex-Dividend On June 27th, 2025 With 34 JPY Dividend Per Share
August 15th (Japan Standard Time) - $HIRAYAMA Holdings(7781.JP)$ is trading ex-dividend on June 27th, 2025.Shareholders of record on June 30th, 2025 will receive 34 JPY dividend per share. The ex-
HIRAYAMA Holdings To Go Ex-Dividend On December 27th, 2024 With 16 JPY Dividend Per Share
August 15th (Japan Standard Time) - $HIRAYAMA Holdings(7781.JP)$ is trading ex-dividend on December 27th, 2024.Shareholders of record on December 31st, 2024 will receive 16 JPY dividend per share.
Dentsu Group revised downwards to 107.1 billion yen in operating profit, from 135.4 billion yen on 24 December.
Dentsu Group (4324) announced a revision of its financial estimates for the fiscal year ending in December 2024, lowering its operating profit from 135.4 billion yen to 107.1 billion yen due to anticipated revenue deficits in Asia-Pacific regions such as China and Australia, resulting in impairment losses. Additionally, expenses related to the sale of its business in Russia, against the background of the Ukrainian invasion, have exceeded expectations. Plus evaluation: Skylark (3197), Medpeer (6095), Yonshan Holdings (3962).
No Data
No Data